Related Experiment Video
Updated: Jul 18, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Ribozyme technology for cancer gene target identification and validation
Qi-Xiang Li1, Philip Tan, Ning Ke
1Immusol, Inc., San Diego, California 92121, USA.
Abstract:
Ribozymes are naturally occurring RNAs with catalytic activities including cis- or trans- cleavage of RNA at predefined sequence sites. This activity has been exploited for specific gene inactivation in cells during the last two decades, and ribozymes have been important functional genomics tools, especially in the pre-RNAi era. It has also been broadly applied in drug target identification and validation in pharmaceutical R&D. This chapter covers many application principles and case studies of ribozyme technology in the areas of cancer research. We also described RNAi applications in some of the same studies for comparison. Although RNAi may be more effective than ribozymes in many respects, they are nonetheless built on many of the same principles.
Insights
Ribozymes are RNA molecules with catalytic abilities used for gene inactivation and drug discovery. This chapter explores ribozyme applications in cancer research, comparing them with RNA interference (RNAi) technologies.
Area of Science:
- Molecular Biology
- Biochemistry
- Genomics
Background:
- Ribozymes are naturally occurring RNAs possessing catalytic activity, enabling specific RNA cleavage.
- Historically, ribozymes were crucial functional genomics tools for gene inactivation, particularly before the advent of RNA interference (RNAi).
- Their application extends to pharmaceutical research and development for drug target identification and validation.
Purpose of the Study:
- To review the principles and case studies of ribozyme technology applications in cancer research.
- To compare ribozyme applications with RNA interference (RNAi) in similar studies.
- To highlight the foundational similarities between ribozyme and RNAi technologies.
Main Methods:
- Review of existing literature on ribozyme and RNAi applications.
- Analysis of case studies in cancer research involving gene inactivation.
- Comparative assessment of ribozyme and RNAi efficacy and principles.
Main Results:
- Ribozyme technology has been widely applied in cancer research for gene inactivation.
- Case studies demonstrate the utility of ribozymes in drug target validation.
- RNA interference (RNAi) often shows greater effectiveness but shares fundamental principles with ribozymes.
Conclusions:
- Ribozymes are valuable tools in cancer research and drug discovery, offering specific gene inactivation capabilities.
- While RNAi may offer advantages in certain contexts, ribozymes remain relevant due to shared underlying mechanisms.
- Understanding ribozyme principles provides insights applicable to other gene modulation technologies.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Ribozymes
Ribozymes can be...
Ribozymes
Ribozymes can be...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Experimental RNAi

